연구성과로 돌아가기
2024 연구자 정보 (192 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Mai, A. (Mai, A) |
Nhan Dan Gia Dinh Hosp, Gen Surg Dept, Ho Chi Minh City, Vietnam |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Mccullough, Keith (Mccullough, K) |
Arbor Res Collaborat Hlth, Ann Arbor, MI USA |
|
|
[JCR상위 6.4] Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus | SCIE | 6.4 | UROLOGY & NEPHROLOGY | KarthikK.Tennankore@nshealth.ca; | ||
|
Nde, Dieudonne Tanue (Nde, DT) |
Kyungpook Natl Univ, Dept Chem & Green Nano Mat, Res Ctr, 80 Daehakro, Daegu City 41566, South Korea |
|
|
[JCR상위 6.4] Voltammetric Aptamer-Based Biochip Featuring Poly Gallic Acid/SnO2-MoO3 Nanocomposite for Selective Tryptophan Detection: Potential Application in Alzheimer's Diagnosis | SCIE | 6.4 | BIOCHEMICAL RESEARCH METHODS;CHEMISTRY, ANALYTICAL;NANOSCIENCE & NANOTECHNOLOGY | kcdurai.rmd@gmail.com;hyejinlee@knu.ac.kr; | ||
|
Oh, Sohee (Oh, S) |
Seoul Natl Univ, Boramae Med Ctr, Dept Biostat, Seoul, South Korea |
|
|
[JCR상위 6.4] Bioimpedance-Guided Fluid Removal in Continuous KRT The VENUS Randomized Clinical Trial | SCIE | 6.4 | UROLOGY & NEPHROLOGY | sejoong@snubh.org; | ||
|
Par-Young, Jennefer (Par-Young, J) |
Yale Univ, Sch Med, Dept Internal Med, Sect Rheumatol Allergy & Immunol, New Haven, CT 06520 USA |
|
|
[JCR상위 6.4] IL-1 receptor 1 signaling shapes the development of viral antigen-specific fi c CD4+ | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | insoo.kang@yale.edu; | ||
|
Park, Ki Hwan (Park, KH) |
Korea Res Inst Biosci & Biotechnol KRIBB, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea |
|
|
[JCR상위 6.4] Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD31; 1; from human pluripotent stem cells | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | jonglee@kribb.re.kr;zhenxing93@kribb.re.kr;jieun622@kribb.re.kr;byung127@kribb.re.kr;kanjon@kribb.re.kr;brightnessd@kribb.re.kr;shhong@kangwon.ac.kr;lee1@knu.ac.kr; | ||
|
Penagos, F. E. (Penagos, FE) |
Hosp San Lucas Cardiol Sureste, Chiapas, Mexico |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Pisoni, Ronald L. (Pisoni, RL) |
Arbor Res Collaborat Hlth, Ann Arbor, MI USA Arbor Res Collaborat Hlth, 3989 Res Pk Dr, Ann Arbor, MI 48108 USA |
|
|
[JCR상위 6.4] Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus [JCR상위 16.2] International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS |
SCIE | 6.4 | UROLOGY & NEPHROLOGY |
KarthikK.Tennankore@nshealth.ca; Brian.Bieber@ArborResearch.org; |
||
|
Qin, S. (Qin, S) |
Jinling Hosp, Canc Ctr Nanjing, Nanjing, Peoples R China |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Racke, Michael K. (Racke, MK) |
Quest Diagnost, 500 Plaza Dr, Secaucus, NJ 07094 USA |
|
|
[JCR상위 6.4] IL-1 receptor 1 signaling shapes the development of viral antigen-specific fi c CD4+ | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | insoo.kang@yale.edu; | ||
|
Ren, Z. (Ren, Z) |
Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Hepat Oncol, Shanghai, Peoples R China |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Rhee, Harin (Rhee, H) |
Pusan Natl Univ Hosp, Dept Internal Med, Div Nephrol, Busan, South Korea |
|
|
[JCR상위 6.4] Bioimpedance-Guided Fluid Removal in Continuous KRT The VENUS Randomized Clinical Trial | SCIE | 6.4 | UROLOGY & NEPHROLOGY | sejoong@snubh.org; | ||
|
Rigatto, Claudio (Rigatto, C) |
Univ Manitoba, Chron Dis Innovat Ctr, Winnipeg, MB, Canada |
JNS-0494-2023 Rigatto, Claudio |
|
[JCR상위 6.4] Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus | SCIE | 6.4 | UROLOGY & NEPHROLOGY | KarthikK.Tennankore@nshealth.ca; | ||
|
Ryu, Dong-Ryeol (Ryu, DR) |
Ewha Womans Univ, Sch Med, Dept Internal Med, Div Nephrol, Seoul, South Korea |
|
|
[JCR상위 6.4] Bioimpedance-Guided Fluid Removal in Continuous KRT The VENUS Randomized Clinical Trial | SCIE | 6.4 | UROLOGY & NEPHROLOGY | sejoong@snubh.org; | ||
|
Sangro, B. (Sangro, B) |
제1저자 |
Clin Univ Navarra, Liver Unit, Pamplona, Spain Clin Univ Navarra, HPB Oncol Area, Pamplona, Spain CIBEREHD, Pamplona, Spain |
AFW-4106-2022 Sangro, Bruno |
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
페이지 이동: